title: [Prevention of genital erosions during treatments with foscarnet of cytomegalovirus infections in AIDS].
authors.forename: W
authors.initials: W
authors.lastname: Lowenstein
authors.forename: J P
authors.initials: JP
authors.lastname: Fadlallah
authors.forename: L
authors.initials: L
authors.lastname: Roudière
authors.forename: C
authors.initials: C
authors.lastname: Deneux
authors.forename: C
authors.initials: C
authors.lastname: Haas
authors.forename: H
authors.initials: H
authors.lastname: Durand
mesh_terms: D000163:Acquired Immunodeficiency Syndrome / Q000150:complications*; D000328:Adult; D000998:Antiviral Agents / Q000009:adverse effects*; D003586:Cytomegalovirus Infections / Q000188:drug therapy / Q000209:etiology*; D017245:Foscarnet; D006801:Humans; D008297:Male; D009894:Opportunistic Infections / Q000150:complications; D010409:Penile Diseases / Q000139:chemically induced*; D010746:Phosphonoacetic Acid / Q000009:adverse effects / Q000031:analogs & derivatives*
chemical_list: D000998:Antiviral Agents; D017245:Foscarnet; D010746:Phosphonoacetic Acid
vernacular_title: Prévention des érosions génitales lors des traitements par foscarnet des infections à cytomégalovirus du SIDA.